SIETES :: 92833 citas

Resultados de la búsqueda por Trifirò,G

1.

Sultana J, Moretti U, Addis A, Caduff P, Capuano A, Kant A, Laporte JR, Lindquist M, Raine J, Sartori D, Trifirò G, Tuccori M, Venegoni M, van Puijenbroek E, Leone R. Workshop on the Italian pharmacovigilance system in the international context: critical issues and perspectives. Drug Saf 2019;42:mayo. [Ref.ID 103115]

2.

Comoretto RI, Rea F, Lucenteforte E, Mugelli A, Trifirò G, Cascini S, Roberto G, Chinellato A, Filippelli A, Corrao G, on behalf of the Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE). Bleeding events attributable to concurrent use of warfarin and other medications in high-risk elderly: meta-analysis and Italian population-based investigation. Eur J Clin Pharmacol 2018;74:1061-70. [Ref.ID 102823]

3.

Poluzzi E, Diemberger I, de Ridder M, Koci A, Clo M, Oteri A, Pecchioli S, Bezemer I, Schink T, Ulrichsen SP, Boriani G, Sturkenboom MCJ, De Ponti F, Trifirò G. Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. Eur J Clin Pharmacol 2017;73:1499-510. [Ref.ID 102126]

4.

Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Froslev T, Molokhia M, Diemberger I, Sturkenboom M. Use of azithromycin and risk of ventricular arrhytmia. Can Med Assoc J 2017;189:E560-8. [Ref.ID 101536]

5.

Oteri A, Mazzaglia G, Pecchioli S, Molokhia M, Ulrichsen SP, Pedersen L, Poluzzi E, De Ponti F, Garbe E, Schink T, Trifirò G. Prescribing pattern of antipsychotic drugs during the years 1996–2010: a population-based database study in Europe with a focus on torsadogenic drugs. Br J Clin Pharmacol 2016;82:487-97. [Ref.ID 100690]

6.

Sultana J, Fontana A, Giorgianni F, Pasqua A, Cricelli C, Spina E, Gambassi G, Ivanovic J, Ferrajolo C, Molokhia M, Ballard C, Sharp S, Sturkenboom M, Trifirò G. The effect of safety warnings on antipsychotic drug prescribing in elderly persons with dementia in the United Kindgom and Italy: a population-based study. CNS Drugs 2016:16 de julio. [Ref.ID 100520]

7.

Nosè M, Recla E, Trifirò G, Barbui C. Antipsychotic drug exposure and risk pneumonia: a systematic review and meta-analysis of observational studies. Pharmacoepidemiol Drug Saf 2015;24:812-20. [Ref.ID 99472]

8.

Cutroneo PM, Isgrò V, Russo A, Ientile V, Sottosanti L, Pimpinella G, Conforti A, Moretti U, Caputi AP, Trifirò G. Safety profile of biological medicines as compared with non-biologicals: an analysis of the Italian spontaneous reporting system database. Drug Saf 2014;37:961-70. [Ref.ID 98406]

9.

Leal I, Romio SA, Schuemie M, Oteri A, Sturkenboom M, Trifirò G. Prescribing pattern of glucose lowering drugs in the United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone. Br J Clin Pharmacol 2013;75:861-8. [Ref.ID 95040]

10.

Trifirò G, Tillati S, Spina E, Ferrajolo C, Alacqua M, Aguglia E, Rizzi L, Caputi AP, Cricelli C, Samani F. A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. Eur J Clin Pharmacol 2013;69:227-36. [Ref.ID 95004]

11.

Oteri A, Trifirò G, Gagliostro MS, Tari DU, Moretti S, Bramanti P, Spina E, Caputi AP, Arcoraci V. Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07. Br J Clin Pharmacol 2010;70:514-22. [Ref.ID 89441]

12.

Trifirò G, Gambassi G, Sen EF, Caputi AP, Bagnardi V, Brea J, Sturkenboom MCJM. Association of community-acquired pneumonia with antipsychotic drug use in elderly patients. A nested case–control study. Ann Intern Med 2010;152:418-25. [Ref.ID 88170]

13.

Polimeni G, Russo A, Catania MA, Aiello A, Oteri A, Trifirò G, Calapai G, Sautebin L, Iacobelli M, Caputi AP. Drug safety information through the Internet: the experience of an Italian website. Drug Saf 2009;32:245-53. [Ref.ID 85697]

14.

Trifirò G, Alacqua M, Corrao S, Moretti S, Tari DU, Galdo M, UVEC group, Caputi AP, Arcoraci V. Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision. Eur J Clin Pharmacol 2008;64:619-25. [Ref.ID 83464]

15.

Trifirò G, Barbui C, Spina E, Moretti S, Tari M, Alacqua M, Caputi AP, Arcoraci V. Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf 2007;16:552-9. [Ref.ID 80205]

16.

Trifirò G, Verhamme KMC, Ziere G, Caputi AP, Stricker BHCH, Sturkenbrrom MCJM. All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiol Drug Saf 2007;16:538-44. [Ref.ID 80204]

17.

Trifirò G, Calogero G, Ippolito FM, Cosentino M, Giuliani R, Conforti A, Venegoni M, Mazzaglia G, Caputi AP. Adverse drug events in emergency department population prospective Italian study. Pharmacoepidemiol Drug Saf 2005;14:333-40. [Ref.ID 73944]

18.

Trifirò G, Espina E, Brignoli O, Sessa E, Caputi AP, Mazzaglia G. Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002. Eur J Clin Pharmacol 2005;61:47-53. [Ref.ID 73468]